Fragment Bb: Evidence for activation of the alternative pathway of the complement system in pregnant women with acute pyelonephritis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 10, 2010, Pages 1085-1090

  Soto, Eleazar ^a,b   Romero, Roberto ^a,b   Vaisbuch, Edi ^a,b   Erez, Offer ^a,b   Mazaki Tovi, Shali ^a,b   Kusanovic, Juan Pedro ^a,b   Dong, Zhong ^a   Chaiworapongsa, Tinnakorn ^a,b   Yeo, Lami ^a,b   Mittal, Pooja ^a,b   Hassan, Sonia S ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute respiratory distress syndrome; asymptomatic bacteriuria; inflammation; innate immunity; pregnancy; Th1 Th2; urinary tract infection

Indexed keywords

COMPLEMENT; COMPLEMENT FRAGMENT BB; UNCLASSIFIED DRUG;

ACUTE PYELONEPHRITIS; ADULT; ARTICLE; BACTERIUM DETECTION; BODY MASS; CITROBACTER KOSERI; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOASSAY; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE;

ADULT; COMPLEMENT FACTOR B; COMPLEMENT PATHWAY, ALTERNATIVE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYELONEPHRITIS; YOUNG ADULT;

EID: 77956609423     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767051003649870     Document Type: Article

References (69)

1. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80-86.
2. Naccasha N, Gervasi MT, Chaiworapongsa T, Berman S, Yoon BH, Maymon E, Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 2001;185:1118-1123. (Pubitemid 33097374)
3. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999;20:114-118.
4. Billington WD. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J.Reprod.Immunol 2003;60:1-11.
5. Medawar P. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. 1953;7:320-338.
6. Kort BA, Cefalo RC, Baker VV. Fatal influenza A pneumonia in pregnancy. Am J Perinatol 1986;3:179-182.
7. Rodrigues J, Niederman MS. Pneumonia complicating pregnancy. Clin Chest Med 1992;13:679-691.
8. Kochar DK, Thanvi I, Joshi A, Shubhakaran, Agarwal N, Jain N. Mortality trends in falciparum malaria - effect of gender difference and pregnancy. J Assoc Physicians India 1999;47:774-778.
9. Catanzarite VA, Willms D. Adult respiratory distress syndrome in pregnancy: report of three cases and review of the literature. Obstet Gynecol Surv 1997;52:381-392.
10. Cunningham FG, Morris GB, Mickal A. Acute pyelonephritis of pregnancy: a clinical review. Obstet Gynecol 1973;42: 112-117.
11. Cunningham FG, Lucas MJ, Hankins GD. Pulmonary injury complicating antepartum pyelonephritis. Am J Obstet Gynecol 1987;156:797-807.
12. Cunningham FG, Lucas MJ. Urinary tract infections complicating pregnancy. Baillieres Clin Obstet Gynaecol 1994;8: 353-373.
13. Pruett K, Faro S. Pyelonephritis associated with respiratory distress. Obstet Gynecol 1987;69:444-446.
14. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353-356.
15. Luppi P, Haluszczak C, Betters D, Richard CA, Trucco M, DeLoia JA. Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol 2002;72: 874-884.
16. Luppi P, Haluszczak C, Trucco M, DeLoia JA. Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol 2002;47:72-81.
17. Gasque P. Complement: a unique innate immune sensor for danger signals. Mol Immunol 2004;41:1089-1098.
18. Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058-1066.
19. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296: 298-300.
20. Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol 2004;5:981-986.
21. Volanakis JE. Overview of the complement system. In: Volanakis JE, Frank MM, editors. The Human Complement System in Health and Disease. New York: Marcel Dekker, Inc.; 1998. pp 9-32.
22. Murphy K, Travers P, Walport M. Innate immunity. In: Murphy K, Travers P, Walport M, editors. Janeways Immunobiology. New York: Garland Science; 2008. pp 39-103.
23. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 2004;138:439-446.
24. Lynch AM, Murphy JR, Byers T, Gibbs RS, Neville MC, Giclas PC, Salmon JE, Holers VM. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol 2008;198: 385-389.
25. Lynch AM, Gibbs RS, Murphy JR, Byers T, Neville MC, Giclas PC, Salmon JE, Van Hecke TM, Holers VM. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol 2008;199: 354-358.
26. Vaisbuch E, Romero R, Erez O, Mazaki-Tovi S, Pedro KJ, Soto E, Gotsch F, Dong Z, Chaiworapongsa T, Kim SK, et al. Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intraamniotic infection/inflammation. J Matern Fetal Neonatal Med 2009;22:905-916.
27. Soto E, Richani K, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, Edwin S, Kim YM, Hong JS, Goncalves L, et al. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med 2005;17:247-252.
28. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996;87:163-168.
29. Chaiworapongsa T, Romero R, Gotsch F, Kusanovic JP, Mittal P, Kim SK, Erez O, Vaisbuch E, Mazaki-Tovi S, Kim CJ, et al. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma. J Matern Fetal Neonatal Med 2010;23: 167-178.
30. Gotsch F, Romero R, Espinoza J, Kusanovic JP, Mazaki- Tovi S, Erez O, Than NG, Edwin S, Mazor M, Yoon BH, et al. Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med 2007;20: 735-744.
31. Kusanovic JP, Romero R, Esoinoza J, Gotsch F, Edwin S, Chaiworapongsa T, Mittal P, Soto E, Erez O, Mazaki-Tovi S, et al. Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis. J Matern Fetal Neonatal Med 2007;20:803-811.
32. Mazaki-Tovi S, Romero R, Vaisbuch E, Chaiworapongsa T, Erez O, Mittal P, Kim SK, Gotsch F, Lamont R, Ogge G, et al. Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection. J Perinat Med 2010;38:9-17.
33. Holers VM. The complement system as a therapeutic target in autoimmunity. Clin Immunol 2003;107:140-151.
34. Thurman JM, Holers VM. The central role of the alternative complement pathway in human disease. J Immunol 2006;176: 1305-1310.
35. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004;4:133-142.
36. Muller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem 1988;57: 321-347.
37. Gotze O, Muller-Eberhard HJ. The C3-activator system: an alternate pathway of complement activation. J Exp Med 1971;134:90s-108s.
38. Xu Y, Narayana SV, Volanakis JE. Structural biology of the alternative pathway convertase. Immunol Rev 2001;180: 123-135.
39. Ward PA, Hill JH. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol 1970;104:535-543.
40. Vogt W. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 1996;195:334-346.
41. Vogt W. Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase. Immunobiology 2000;201: 470-477.
42. Huber-Lang M, Younkin EM, Sarma JV, Riedemann N, McGuire SR, Lu KT, Kunkel R, Younger JG, Zetoune FS, Ward PA. Generation of C5a by phagocytic cells. Am J Pathol 2002;161:1849-1859.
43. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res 2002;4(Suppl. 3):S279-S293.
44. Nakagawa K, Sakiyama H, Tsuchida T, Yamaguchi K, Toyoguchi T, Masuda R, Moriya H. Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody. Ann Rheum Dis 1999;58:175-181.
45. Neumann E, Barnum SR, Tarner IH, Echols J, Fleck M, Judex M, Kullmann F, Mountz JD, Scholmerich J, Gay S, et al. Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum 2002;46:934-945.
46. del Zoppo GJ. In stroke, complement will get you nowhere. Nat Med 1999;5:995-996.
47. Huang J, Kim LJ, Mealey R, Marsh HC Jr., Zhang Y, Tenner AJ, Connolly ES Jr., Pinsky DJ. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999;285:595-599.
48. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308: 421-424.
49. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, et al. Complement factor H variant increases the risk of agerelated macular degeneration. Science 2005;308:419-421.
50. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-389.
51. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 2009; 50:5818-5827.
52. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, et al. Arthritis critically dependent on innate immune system players. Immunity 2002;16:157-168.
53. Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J Immunol 2006;177:1904-1912.
54. Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int 2004;65:129-138. (Pubitemid 38037497)
55. Goring K, Huang Y, Mowat C, Leger C, Lim TH, Zaheer R, Mok D, Tibbles LA, Zygun D, Winston BW. Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C. Am J Physiol Cell Physiol 2009;296:C1140-C1150.
56. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003;112:1644-1654.
57. Mao D, Wu X, Deppong C, Friend LD, Dolecki G, Nelson DM, Molina H. Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 2003;19:813-822.
58. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001;2:64-68.
59. Xu C, Mao D, Holers VM, Palanca B, Cheng AM,Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000;287:498-501.
60. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
61. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, Hassan SS. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007; 50:652-683.
62. Vaisbuch E, Romero R, Erez O, Mazaki-Tovi S, Kusanovic JP, Soto E, Dong Z, Chaiworapongsa T, Kim SK, Ogge G, et al. Activation of the alternative pathway of complement is a feature of preterm parturition but not of spontaneous labor at term. Am J Reprod Immunol 2010; E-pub Feb 16. PMID: 20163401.
63. Efrati P, Presentey B, MargalithM, Rozenszajn L. Leukocytes of normal pregnant women. Obstet Gynecol 1964;23: 429-432.
64. Comeglio P, Fedi S, Liotta AA, Cellai AP, Chiarantini E, Prisco D, Mecacci F, Parretti E, Mello G, Abbate R. Blood clotting activation during normal pregnancy. Thromb Res 1996;84:199-202.
65. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52:176-182.
66. Hopkinson ND, Powell RJ. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases. J Clin Pathol 1992;45:66-67.
67. Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, Edwin S, Kim YM, Hong JS, Mazor M. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 2005;17:239-245.
68. von Dadelszen P, Watson RW, Noorwali F, Marshall JC, Parodo J, Farine D, Lye SJ, Ritchie JW, Rotstein OD. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999;181:408-414.
69. Sacks GP, Redman CW, Sargent IL. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clin Exp Immunol 2003;131:490-497.